Bicara Therapeutics Inc. ($BCAX)
Filing Information
| Accession Number | 0001628280-26-026089 |
|---|---|
| Form Type | 4 |
| Filing Date | Apr 20, 2026 |
| Document | View SEC Filing |
Transactions
9
Total Shares
90,520
Total Value
$514,351.80
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Director | Common Stock | โ | Apr 16, 2026 | Exercise/Conversion | 8,226 | $4.44 | $36,497.94 | 347,618 | Direct | โ | View Details | |
Director | Common Stock | โ | Apr 16, 2026 | Exercise/Conversion | 7,454 | $3.79 | $28,249.17 | 355,072 | Direct | โ | View Details | |
Director | Common Stock | โ | Apr 16, 2026 | Exercise/Conversion | 7,080 | $5.45 | $38,612.20 | 362,152 | Direct | โ | View Details | |
Director | Common Stock | โ | Apr 20, 2026 | Exercise/Conversion | 15,000 | $3.79 | $56,847.00 | 377,152 | Direct | โ | View Details | |
Director | Common Stock | โ | Apr 20, 2026 | Sale | 15,000 | $23.61 | $354,145.50 | 362,152 | Direct | โ | View Details | |
Director | Stock Option (Right to Buy) | Derivative | Apr 16, 2026 | Exercise/Conversion | 8,226 | $0.00 | $0.00 | 56,684 | Direct | โ | View Details | |
Director | Stock Option (Right to Buy) | Derivative | Apr 16, 2026 | Exercise/Conversion | 7,454 | $0.00 | $0.00 | 130,546 | Direct | โ | View Details | |
Director | Stock Option (Right to Buy) | Derivative | Apr 16, 2026 | Exercise/Conversion | 7,080 | $0.00 | $0.00 | 558,432 | Direct | โ | View Details | |
Director | Stock Option (Right to Buy) | Derivative | Apr 20, 2026 | Exercise/Conversion | 15,000 | $0.00 | $0.00 | 161,107 | Direct | โ | View Details |